Marveling at the remarkably positive vibe emerging from the recent Democratic National Convention in Chicago, Philadelphia Inquirer columnist Will Bunch observed:

That "new power dynamic" Bunch references is embodied in Vice President Kamala Harris' open alignment with the economic needs of the vast majority of Americans who make up the working and middle classes.

Whether or not the recommendation from Sen. Bernie Sanders, this nation's most progressive Senator, was a factor, it is clear that Harris' decision to pick one of the nation's most progressive Governors, Tim Walz of Minnesota --- a governor who gleefully signed a bill for free breakfast and lunch for all school children into law --- as her Vice-Presidential pick, reflects her commitment to progressive values.

As Georgia's Republican former Lt. Gov. Geoff Duncan made clear during his DNC speech, there's no need for Harris to move to the right to attract voters from outside of the progressive realm. The threat to democracy posed by Donald Trump, Project 2025 and the MAGA cult, along with the Democrats' commitment to "freedom", "patriotism" and respect for the rule of law, will be enough to attract honest conservative voters irrespective of whether they still call themselves Republicans or now describe themselves as either former Republicans or independents.

By adhering to her progressive economic values --- whether it comes to support for organized labor, an increase in the federal minimum wage, the expansion of social safety net programs, tax increases on the wealthy, the expansion of accessible health care and a crackdown on corporate price gouging --- Harris can not only maintain authenticity but also take advantage of the fact that an overwhelming majority of the American electorate both want and need such progressive economic policy initiatives...

In the second loss for Big Pharma in less than a month, the Trump-appointed Chief Judge of the Delaware U.S. District Court rejected a Constitutional challenge to a law adopted by Democrats in Congress and signed by President Joe Biden which allows for the negotiation of drug prices for Medicare.

Last week, in a 45-page Memorandum Opinion issued in AstraZeneca Pharmaceuticals v. Becerra, Chief Judge Colm F. Connolly summarily rejected the drug manufacturer's assertion that provisions of the Inflation Reduction Act of 2022 (IRA), authorizing the Centers for Medicare and Medicaid Services (CMS) to negotiate prescription drug prices, violates the pharmaceutical industry's 5th Amendment rights.

The 5th Amendment provides that no person shall "deprived of...property without due process of law." A person (in this instance, a corporation) cannot be unlawfully deprived of a property right that does not exist.

The IRA, which President Biden signed into law on Aug. 16, 2022 --- an Act that every House Republican opposed --- reversed a provision of the Medicare Part D law, enacted in 2003 during the George W. Bush administration, which statutorily prevented CMS from negotiating prescription drug prices.

According to a press release issued by the Department of Health and Human Services (HHS), the government's ability to negotiate pricing is essential given that "the United States pays three times more for prescription drug prices than any other developed nation." The conservative federal judge in Delaware ruled that the 5th Amendment due process clause doesn't create a pharmaceutical property right to force the federal government to agree to pay those higher prices...

The state of California is embarking on a ground-breaking effort to manufacture and distribute a life-saving drug. The plan also deals a first major blow to private pharmaceutical companies that have long abused the nation's legal system for profit at the expense of the health of the citizenry.

"On my first day in office I signed an Executive Order to put California on a path towards creating our own prescription drugs," Democratic Governor Gavin Newsom declared in a July 7 video posted to Twitter, referencing his inauguration promise in January of 2019. "And now it's happening".

Newsom's statement came in the wake of his approval of a Golden State Budget Proposal that will invest $50 million into development and $50 million more into a State-owned facility that will manufacture and distribute generic (aka biosimilar) insulin to Californians at slightly above cost.

If it succeeds, California, which has the world's 5th largest economy, will not only become the first State, but also the only government, other than Cuba, to embrace the socialized production of generic medications. (Although Cuba develops and manufactures its own generic medications and provides free "preventative medical care, diagnostic tests and medications for hospitalized patients", Pharmacy Times reported, "Cubans pay out-of-pocket for outpatient medications.")

California's progressive Democratic Governor pointed to the extraordinarily high cost of insulin as a form of "market failure" that justifies his embrace of socialized medications. His decision to allow the Golden State to produce its own generic insulin also highlights the immoral manipulation of the nation's patent laws by for-profit drug companies...